Literature DB >> 2538269

Liver resection for hepatocellular carcinoma: results from 150 consecutive patients.

N Nagasue1, H Yukaya.   

Abstract

During the past 6 years, 150 consecutive hepatic resections were performed for hepatocellular carcinoma on 129 male and 21 female patients. Their ages ranged from 17 years to 78 years, with an average of 57.0 years. All but two patients had an underlying parenchymal disease of the liver; 131 had liver cirrhosis, 16 chronic hepatitis, and one liver fibrosis. The operations performed were extended right lobectomy in 10 cases, right lobectomy in 13, left lobectomy in 5, left lateral segmentectomy in 11, other segmentectomies in 31, and partial wedge resection in 80 instances. The operative and in-hospital mortality rates were 6.0% and 12.0% respectively. In the 122 patients with curative resection, the 1-, 3- and 5-year survival rates were 75.2%, 49.0% and 30.0% respectively. The 1- and 3-year survival rates were 14.3% and 7.1% in the 28 patients with palliative resection. The tumor size and Child's classification generally reflected the survival rate.

Entities:  

Mesh:

Year:  1989        PMID: 2538269     DOI: 10.1007/bf00647246

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  19 in total

1.  Appraisal of hepatic resection in the treatment of minute hepatocellular carcinoma associated with liver cirrhosis.

Authors:  N Nagasue; H Yukaya; Y C Chang; Y Ogawa; N Ota; N Kimura; T Nakamura
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

Review 2.  Resectional therapy for primary malignant hepatic tumors.

Authors:  T Y Lin
Journal:  Int Adv Surg Oncol       Date:  1979

3.  Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion.

Authors:  N Nagasue; H Yukaya; Y Ogawa; S Hirose; M Okita
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

4.  The surgical management of primary hepatocellular carcinoma in Uganda.

Authors:  N W Harrison; D Dhru; A Primack; D Bhana; S K Kyalwazi
Journal:  Br J Surg       Date:  1973-07       Impact factor: 6.939

5.  Tolerance of the cirrhotic liver to normothermic ischemia. A clinical study of 15 patients.

Authors:  N Nagasue; H Yukaya; S Suehiro; Y Ogawa
Journal:  Am J Surg       Date:  1984-06       Impact factor: 2.565

6.  An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies.

Authors:  J Okamura; S Horikawa; T Fujiyama; M Monden; J Kambayashi; O Sikujara; M Sakurai; C Kuroda; H Nakamura; G Kosaki
Journal:  World J Surg       Date:  1982-05       Impact factor: 3.352

7.  Modified distal splenorenal shunt with expanded polytetrafluoroethylene interposition.

Authors:  N Nagasue; Y Ogawa; H Yukaya; S Hirose
Journal:  Surgery       Date:  1985-11       Impact factor: 3.982

8.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.

Authors:  P P Anthony; K G Ishak; N C Nayak; H E Poulsen; P J Scheuer; L H Sobin
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

9.  Major hepatic resection for neoplasia: personal experience in 108 patients.

Authors:  J G Fortner; D K Kim; B J Maclean; M K Barrett; S Iwatsuki; A D Turnbull; W S Howland; E J Beattie
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

10.  Hepatic resection for trauma, tumour and biliary obstruction.

Authors:  L H Blumgart; J K Drury; C B Wood
Journal:  Br J Surg       Date:  1979-11       Impact factor: 6.939

View more
  12 in total

1.  The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection.

Authors:  Geoffrey Paul Kohn; Mehrdad Nikfarjam
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

2.  Influence of high- and low-volume liver surgery in gallbladder carcinoma.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma.

Authors:  C M Lo; E C Lai; C L Liu; S T Fan; J Wong
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).

Authors:  H Yodono; S D Takekawa; K Tarusawa; I Ikami; J Kanehira; Y Saito; S Takahashi; T Sasaki; N Nishi; T Kimura
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.

Authors:  Skye C Mayo; Andrew D Shore; Hari Nathan; Barish H Edil; Kenzo Hirose; Robert A Anders; Christopher L Wolfgang; Richard D Schulick; Michael A Choti; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2011-05-18       Impact factor: 3.647

6.  Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: a comparison with transcatheter arterial chemoembolization.

Authors:  K S Jeng; F S Yang; H J Chiang; I Ohta
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

7.  A risk model to predict 90-day mortality among patients undergoing hepatic resection.

Authors:  Omar Hyder; Carlo Pulitano; Amin Firoozmand; Rebecca Dodson; Christopher L Wolfgang; Michael A Choti; Luca Aldrighetti; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-03-09       Impact factor: 6.113

Review 8.  [Liver resections for primary liver malignancies. Personal results and analysis of the literature].

Authors:  J Zieren; H U Zieren; J M Müller
Journal:  Langenbecks Arch Chir       Date:  1994

9.  En bloc resection for extensive hepatocellular carcinoma: is it advisable?

Authors:  K S Jeng; B F Chen; H J Lin
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

10.  Sonographic characteristics of recurrent hepatocellular carcinoma.

Authors:  T Shibata; H Sakahara; S Kawakami; J Konishi
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.